Rocket Pharmaceuticals is trading 5% up at $3.71, with the move appearing primarily sector-driven as the biotech sector gains 2.06% during the August 25, 2026, regular session.
- No new company-specific announcement appears on Rocket Pharmaceuticals’ investor-relations release list.
- Its latest releases are dated August 10 and August 3.
- Broader risk-on sentiment and positive biotechnology momentum are supporting the move.